Hikma Pharmaceuticals PLC Annual Report 2011

Since Hikma was founded, we have grown into a successful multinational pharmaceutical group. Our business today is diverse in its product line and the breadth of its geographic coverage. This diversification will ensure that we maintain our track record of strong growth

Chairman's statement

Hikma’s success continues to be underpinned by its diverse business model, which combines an extensive presence and experience...

Read more of the Chairman's review

CEO’s review

In 2011, we continued our track record of doubling sales every four years while at the same time achieving a number of strategic milestones...

Read more of the CEO's review

Group at a glance

We develop, manufacture and market generic pharmaceutical products within three core businesses. We are also a leading licensing partner...

Read more about the group

Delivering our strategy

In 2011, Branded revenue increased by 12.1% to $441.9 million, compared to $394.2 million in 2010.

Read more about how we deliver our strategy

Financial highlights

1 Before the amortisation of intangible assets (excluding software) and exceptional items
2 Reported profit before interest, tax, depreciation and amortisation